The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

We’ve recommended mirvetuximab soravtansine (also called Elahere and developed by AbbVie) for treating folate receptor-alpha-positive platinum-resistant epithelial ovarian, fallopian tube or primary ...

"Somewhere between 35-80% of people with PMOS experience insulin resistance, making weight management important." ...

A £600 million tranche of government funding for a key part of the UK's life sciences strategy – expanding the country's ...

"If you are diagnosed with Polyendocrine Metabolic Ovarian Syndrome, it doesn't mean that you are destined to have poor ...

Persistent fatigue, sugar cravings and irregular periods are often blamed on stress or a hectic lifestyle. However, doctors ...

"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

One in eight women will receive a diagnosis that can impact their fertility and overall health the rest of their lives.

A growing body of epidemiological evidence points to an inverse relationship between cancer and Alzheimer’s disease (AD): individuals with a cancer ...

Multiple guidelines recommend ongoing breast cancer risk assessment for women, beginning by age 25, to identify individuals at increased risk who may need enhanced breast cancer screening. 1,2. A risk ...

It is the first time in several election cycles National Democrats are pumping resources into Texas. An impasse in the ...